Progestin treatment for the prevention of preterm birth

24Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Progestin supplementation appears to be a promising approach to both preventing initiation of preterm labor and treating it once it is already established, given the role of progesterone in maintaining pregnancy, as well as support from basic and clinical research. Progesterone and 17α- hydroxyprogesterone acetate slow the process of cervical ripening, and this is the rationale for prophylactic long-term progestin supplementation mostly studied so far. However, progesterone (but not 17α-hydroxyprogesterone acetate) also inhibits myometrial activity even after the cervix has already ripened. Moreover, these effects depend greatly on the vehicle used and the route of administration. Understanding different mechanisms of action, as well as the importance of progestin formulation, vehicle and route of administration, is the key to finding the optimal progestin treatment for prevention of preterm birth. © 2011 Nordic Federation of Societies of Obstetrics and Gynecology.

Cite

CITATION STYLE

APA

Lucovnik, M., Kuon, R. J., Chambliss, L. R., Maner, W. L., Shi, S. Q., Shi, L., … Garfield, R. E. (2011, October). Progestin treatment for the prevention of preterm birth. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/j.1600-0412.2011.01178.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free